It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Forces play diverse roles in vascular development, homeostasis and disease. VE-cadherin at endothelial cell-cell junctions links the contractile acto-myosin cytoskeletons of adjacent cells, serving as a tension-transducer. To explore tensile changes across VE-cadherin in live zebrafish, we tailored an optical biosensor approach, originally established in vitro. We validate localization and function of a VE-cadherin tension sensor (TS) in vivo. Changes in tension across VE-cadherin observed using ratio-metric or lifetime FRET measurements reflect acto-myosin contractility within endothelial cells. Furthermore, we apply the TS to reveal biologically relevant changes in VE-cadherin tension that occur as the dorsal aorta matures and upon genetic and chemical perturbations during embryonic development.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 Institute for Molecular Bioscience, Genomics of Development and Disease division, The University of Queensland, St Lucia, QLD, Australia
2 Institute for Molecular Bioscience, Cell Biology and Molecular Medicine division, The University of Queensland, St Lucia, QLD, Australia; Centre for Cancer Biology, SA Pathology and the University of South Australia, Adelaide, SA, Australia
3 Garvan Institute of Medical Research, Darlinghurst, Sydney, NSW, Australia
4 Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, VA, USA
5 Biozentrum der Universität Basel, Basel, Switzerland
6 Yale Cardiovascular Research Center and Department of Internal Medicine, Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA
7 Institute for Molecular Bioscience, Cell Biology and Molecular Medicine division, The University of Queensland, St Lucia, QLD, Australia